TRANSLATIONAL RELEVANCE
Nelfinavir also decreases vascular endothelial growth factor (VEGF)/hypoxiainducible factor-1α (HIF-1α) expression, tumor hypoxia, and angiogenesis (6) .
Additionally, nelfinavir inhibits signal transducer and activator of transcription 3 (STAT3) and extracellular signal-regulated kinase 1/2 (ERK1/2) (7) . Such pleiotropic activities demonstrate that nelfinavir has multiple off target effects.
Liposarcomas arise from adipocytes or their precursors (8).
Chemotherapy for recurrent or metastatic liposarcomas is generally palliative (9) .
We hypothesized that nelfinavir would inhibit liposarcoma growth because HIV PI use is linked to a clinical syndrome of peripheral lipoatrophy known as "HIV protease-induced lipodystrophy syndrome" (10) . In this syndrome, adipocyte apoptosis is observed and associated with alteration of sterol regulatory element binding protein-1 (SREBP-1) expression (11) (12) (13) .
SREBPs are synthesized as inactive, membrane-bound precursors in the endoplasmic reticulum (ER), tethered at their carboxy-terminal domain by SREBP cleavage-activating protein (SCAP) (14, 15) . In the presence of SREBPs (16) . Upon cholesterol depletion, SCAP and Insig fail to interact, the SREBP-SCAP complex is transported to the Golgi apparatus, where it is processed in two sequential proteolytic cleavage steps by Site-1 protease (S1P), a subtilisin-like serine protease, and Site-2 protease (S2P), a metalloprotease protease, to release the transcriptionally-active, amino-terminal fragment to the nucleus in an evolutionarily-conserved process, regulated intramembrane proteolysis (RIP) (16) (17) (18) . SREBP-1 is a key transcription factor necessary for adipogenesis, cholesterol biosynthesis and adipocyte differentiation (19) . Its target genes include genes related to cholesterol synthesis such as fatty-acid synthase (FASN) (20) and anti-proliferative and pro-apoptotic genes such as:
, Fas and Bax (21, 22) .
Most proteins fold and mature in the ER lumen. An imbalance between the load of unfolded proteins that enter the ER (ER stress) and the capacity of the cellular machinery that handles this load (unfolded protein response, UPR) eventually triggers apoptosis (23, 24) . Activating transcription factor 6 (ATF6) is a precursor ER-bound transcription factor that activates UPR genes. When unfolded proteins accumulate in the ER, ATF6 is RIP-processed by S1P and S2P to release its amino-terminal domain analogous to SREBPs (18) .
Our group has shown that nelfinavir induces a G 1 cell cycle block and apoptosis selectively in liposarcoma cell lines as a consequence of up-regulation of SREBP-1 expression (3). In the present report, we demonstrate that nelfinavir- the nucleus. These results provide new insight into the mechanism for nelfinavirmediated ER stress in liposarcomas.
MATERIALS AND METHODS
Cell culture SW872 dedifferentiated liposarcoma was purchased from the American Type Culture Collection (Virginia, USA) (25) . LiSa-2 pleomorphic liposarcoma cell line was a kind gift from Dr. Silke Brüderlein (University of Ulm, Ulm, Germany) (26), and maintained in Iscove's modified Dulbecco's medium /RPMI in a 4:1 ratio supplemented with 10% fetal bovine serum, 2 mM Lglutamine, and 0.1 mg/ml gentamicin. The cells were DNA fingerprinted to confirm identity as previously described (27) . In the siRNA knockdown study, S1P, S2P or equal amounts of S1P and S2P siRNA were transfected on day 2. On day 3, cells were transfected with pSREBP-1-EGFP. On day 4, nucleus was stained for time-lapse imaging as described. The first image (t=0 h) was recorded 24 hr after pSREBP-1-EGFP transfection (48 hr after siRNA transfection) and recorded every 2 hr for 12 hr.
Chemicals and reagents
Images were generated using Multi Time Macro in the LSM 510 software and was analyzed using LSM Image Browser and Concatination Macro software. Measurement of ER stress. S1P, S2P or equal amounts of S1P and S2P siRNA were transfected on day 1. Cell lysates for Western blot detection of GRP78 were prepared from the transfected cells on day 3. Nelfinavir treated LiSa-2 cells were collected at 24 hr for Western blot detection of GRP78.
Thapsigargin (0.5 µM) served as a positive control for ER stress induction.
Statistical Analysis Data were presented as the mean ± SD of three independent experiments. Group comparisons for continuous data were done with student's t-test for independent means or two-way ANOVA.
Research. (Fig. 2A) . The results are demonstrated quantitatively in Fig. 2A with the half-life (T 1/2 ) of 2 hr for control and 13 hr for NFV treated cells. Similarly, (Fig. 2B) was also tested in LiSa-2 cells, and demonstrates a similar dosedependent increase of precursor ATF6 (90 KDa) by NFV, and prolonged T 1/2 from 6 to 9 hr (Supplemental Data). Importantly, NFV did not alter SREBP-1 ubiquitination nor acetylation (Supplemental Data). siRNA reduced target S1P or S2P RNA level >90% (Fig. 3A) . Western blot confirms an accumulation of precursor SREBP-1 (Fig. 3A) in S1P or/and S2P siRNA transfected cells. Notably, time-lapse microscopy demonstrates the absence of nuclear GFP in both S1P and S2P siRNA-transfected cells whereas control cells show diffuse nuclear fluorescence (Figs. 3B and 3C ). These results indicate inhibition of S1P and S2P results in potent inhibition of SREBP-1 trafficking to the nucleus. Significantly, combined S1P and S2P knockdown leads to the greatest inhibition of SREBP-1 movement, as shown by nearly complete exclusion of fluorescence in the nucleus (Fig. 3D) . To determine the consequence of S1P and S2P knockdown on cell proliferation, a fluorescencebased assay, DIMSCAN, was performed Fig. 4A shows S1P or S2P siRNA reduces cell survival to 85% of control at 72 hrs. Notably, both siRNAs reduce survival by 50%. These results demonstrate that inhibition of S1P and/or S2P-mediated RIP of SREBP-1 leads to cell death, which supports the notion that S1P and/or S2P may be potential targets of NFV. (Figs. 4B) . In contrast, treatment of LiSa-2 cells with 1,10-phenanthroline, a metalloprotease-specific S2P inhibitor, leads to both dose-and time-dependent accumulation of precursor SREBP-1 and ATF6 (Fig. 4C) , similar to the phenotype observed for NFV (31) . Likewise, 1,10-phenanthroline leads to dose-dependent apoptosis (Fig. 4D ) which highly suggests that NFV inhibits the proteolytic activity of S2P. gm/kg/day, or 2 gm/kg/day by oral gavage, the mice were euthanized and subjected to necropsy. Figure 5B demonstrates minimal or no weight loss associated with NFV with either dose level (P<0.05). Daily cage examination failed to demonstrate diarrhea or its pre-determined surrogate, 10% weight loss.
Nelfinavir inhibits intracellular
Histologic evaluation of liver and bone marrow demonstrated no microscopic difference in liver architecture nor levels of myeloid nor erythroid precursors between control and NFV-treated mice (data not shown).
To determine the pharmacokinetics of oral NFV in vivo, cohorts of 3 mice underwent a single, oral gavage with 500 mg/kg of NFV, and the mice were euthanized for cardiac puncture at the indicated time points. The results demonstrate at a dose of 500 mg/kg, a peak plasma concentration of NFV that approximates the in vitro biologically active dose (~10 µM) is reached in 1 hr, and remains steady for 8 hr (Fig. 5C ). These data suggest that twice daily dosing is feasible for long-term NFV dosing.
Nelfinavir and S2P siRNA induce ER stress. NFV induces ER stress (4) . To determine whether S2P inhibition also induces ER stress, siRNA targeting S1P, S2P, or S1P plus S2P were transfected into LiSa-2 cells, and expression of the ER stress response protein GRP78 was evaluated. Thapsigargin (TG) served as a positive control for ER stress induction. Fig. 6A shows that TG, high dose NFV, and S2P or S1P plus S2P siRNA strongly induce expression of GRP78, whereas control and S1P siRNA alone does not. These results are consistent with the hypothesis that NFV inhibits S2P activity, which induces ER stress. 
DISCUSSION
Nelfinavir is a PI that was originally developed for therapy against HIV.
Nelfinavir may inhibit cancer growth via multiple pathways (1) (2) (3) (4) (5) (6) . Recently, a study in ovarian cancer suggested a novel additional mechanism that nelfinavir may target cancer stem cells (33) . These reports have led support for the use of nelfinavir alone or in combination with radiation and/or chemotherapy for advanced cancers in several clinical trials including our ongoing trial in liposarcomas (5, 34) .
Liposarcomas are one of the most common soft tissue sarcomas, and outcomes for recurrence remains poor. They may be particularly sensitive to nelfinavir, because it interferes with maturation of SREBP-1, an adipocytic transcription factor (19) . Our data strongly suggests that nelfinavir inhibits liposarcoma proliferation, and promotes apoptosis by inhibiting RIP processing of SREBP-1 and ATF6. This results in accumulation of unfolded SREBP-1 and ATF6 precursor proteins (ER stress), and inhibition of the UPR because ER stress-induced activation of ATF6 is neutralized.
Regulation of SREBP-1 and ATF6 is similar ( Figure 6B ). Both transcription factors are synthesized as ER transmembrane proteins (precursor) and transported to the Golgi where RIP occurs. Luminal S1P cleavage occurs first, followed by intra-membrane S2P cleavage, which liberates the transcriptionallyactive amino-terminal segments of SREBP-1 and ATF6 to migrate to the nucleus to transactivate sterol biosynthesis or UPR activation genes.
Research. 
Our previous data showed precursor and processed forms of SREBP-1 were consistently upregulated by nefinavir in various liposarcoma cell lines (3).
Our present results show nelfinavir induces similar up-regulation of ATF6 (Fig. 2) .
Confocal, time-lapse microscopy ( Fig. 3) activity, which is supported by the demonstration that siRNA-mediated knockdown of S2P, but not S1P, induces ER stress (Fig. 6A) . Interestingly, HIV PIs inhibit proteolytic activation of zinc metalloproteinase, ZMPSTE24, and matrix metalloproteinase-2 (MMP2) (35, 36) . S2P is also a metalloprotease, and likely shares a similar domain with other family members recognized by a PI.
Our current model illustrated in Fig. 6B demonstrates that nelfinavirinduced up-regulation of precursor SREBP-1 and ATF6 is mediated through inhibition of S2P, which leads to inhibition of RIP. Confirmatory support remains pending our current efforts to purify S2P protein for enzymatic cleavage assays.
The precursor proteins are retained in the cytoplasm, their transport to the nucleus is halted, and transcriptional activation of target genes is blocked.
Accumulation of unprocessed SREBP and ATF6 induces ER stress, and a deficient UPR leads to caspase-dependent apoptosis.
Research. A notable target gene of SREBP is FASN. One of the hallmarks of cancer is increased de novo fatty acid (FA) synthesis, referred to as the "lipogenic phenotype" (43, 44) . FAs are essential constituents of all biological membrane lipids, and are important substrates for energy metabolism (44) . FASN catalyzes the terminal steps of long chain FA synthesis (44) . FASN is overexpressed in many cancers (43, 44) . Inhibition of FASN by RNAi or small molecules inhibits growth and survival of tumors (44) (45) (46) . We also observed nelfinavir-dependent reduction in FASN expression, which was mediated through depletion of transcriptionally-active SREBP-1. This provocative result suggests that nelfinavir may possess anticancer activity in other cancers which exhibit a "lipogenic phenotype," an avenue that we are currently actively pursuing.
In summary, this study demonstrates that nelfinavir induces liposarcoma apoptosis through ER stress induction and deficient UPR. These biological effects arise from accumulation of precursor SREBP-1 and ATF6, as a result of S2P-regulated RIP cleavage inhibiton. To our knowledge, this is the first report of a novel strategy targeting S2P and RIP for cancer therapeutics.
